# Evaluation of Pharmacokinetic and Safety of NVP-2102 and NVP-2102-R in Healthy Subjects

> **NCT05023031** · PHASE1 · COMPLETED · sponsor: **NVP Healthcare** · enrollment: 53 (actual)

## Conditions studied

- Healthy Subjects

## Interventions

- **DRUG:** NVP-2102
- **DRUG:** NVP-2102-R

## Key facts

- **NCT ID:** NCT05023031
- **Lead sponsor:** NVP Healthcare
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-10-05
- **Primary completion:** 2021-12-24
- **Final completion:** 2022-01-15
- **Target enrollment:** 53 (ACTUAL)
- **Last updated:** 2022-01-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05023031

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05023031, "Evaluation of Pharmacokinetic and Safety of NVP-2102 and NVP-2102-R in Healthy Subjects". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05023031. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*